The agreement between Nanologica and Yunbo Technology (Beijing) Co. stretches over six years (2021–2026) and means...
Terns Pharmaceuticals, a global biopharmaceutical company focused on discovering and developing innovative therapie...
Ping An Insurance (Group) Company of China, Ltd. has received global recognition for its achievements in artificial...
BeiGene, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecula...
US based Integrated DNA Technologies (IDT) has announced that is has entered into a strategic cooperation with Chos...
Johnson & Johnson Innovation, Division of Johnson & Johnson (China) Investment Ltd., on 27 June 2019, announced ...
Yisheng Biopharma, a biopharmaceutical company focusing on research, development, manufacturing, sales and marketin...
MicroPort Orthopedics, a medical device company associated with China headquartered MicroPort Scientific Corporation, th...
Innovent Biologics and Eli Lilly and Company have jointly announced that the National Medical Products Administration (N...
Merck, the world's leading technology company, has launched its first “Mobile Lab” on protein research ...
Loxo Oncology, Inc., a wholly owned subsidiary of Eli Lilly and Company, has entered into a strategic partnership agreem...
Target Health Inc. and dMed Biopharmaceuticals Company Limited have joined forces to help Western and Chinese biopharma ...
GENFIT, a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and ...
XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel s...
BeiGene, Ltd., a China headquartered commercial-stage biotechnology company focused on developing and commercializing in...
Henlius, a leading biotech company in China developing both biosimilar and innovative biologics, on 21 June 20...
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announc...
